Unity Biotechnology Inc. (UBX)
NASDAQ: UBX
· Real-Time Price · USD
0.77
-0.02 (-1.91%)
At close: Jun 27, 2025, 3:59 PM
0.80
3.64%
After-hours: Jun 27, 2025, 05:58 PM EDT
-1.91% (1D)
| Bid | 0.78 |
| Market Cap | 13.29M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -27.5M |
| EPS (ttm) | -1.63 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -0.97 |
| Analyst | Hold |
| Ask | 0.8 |
| Volume | 52,373 |
| Avg. Volume (20D) | 277,854 |
| Open | 0.78 |
| Previous Close | 0.79 |
| Day's Range | 0.77 - 0.78 |
| 52-Week Range | 0.66 - 3.10 |
| Beta | 1.06 |
Analyst Forecast
According to 0 analyst ratings, the average rating for UBX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-4.46%
UBX stock has given up its prior loss. Unity Biote...
Unlock content with
Pro Subscription
1 month ago
-4.46%
Unity Biotechnology shares are trading lower after the company announced 36-week results from its Phase 2b ASPIRE clinical trial.
